Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Pfizer ( PFE) CEO Albert Bourla said Tuesday he has a "special relationship" with President Trump, cemented during the ...

Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer ...

Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

CEO Albert Bourla said on Tuesday that he and other pharma executives discussed President Donald Trump’s recent call for big pharma to offer direct-to-consumer marketing as part of his Most Favored ...

The drug maker reports second-quarter earnings Tuesday, and investors continue to eye a list of glaring problems.

Trump posted individual letters he sent 17 drugmakers, including Eli Lilly, GSK, Pfizer, Regeneron, Merck, Pfizer and Novo ...

President Trump’s latest tariff threat has targeted a sector that’s already hobbled.

At first glance, Pfizer delivered a strong Q2 and upped its 2025 full-year EPS guidance. Click here to find out why I rate ...

Pfizer Inc.’s stock was rallying Tuesday after the drug giant lifted its 2025 adjusted profit estimate, on the heels of a 10% jump in second-quarter revenue on strength in its Vyndaqel heart ...

U.S. drugmaker Pfizer raised its full-year profit forecast on Tuesday after reporting better-than-expected results for the ...